Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (EU) č. 618/2012

xx xxx 10. července 2012,

xxxx&xxxxxx;x xx xxx účely xřxxxůxxxxx&xxxxxx; vědecko-technickému pokroku xěx&xxxxxx; nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x Xxxx (XX) č. 1272/2008 x klasifikaci, xxxxčxx&xxxxxx;x&xxxxxx; x balení látek x xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx xxx EHP)

XXXXXXX&Xxxxxx; XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Evropské unie,

x&xxxx;xxxxxxx xx xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Rady (XX) č.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx 2008 o klasifikaci, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; látek x&xxxx;xxěx&xxxxxx;, o změně a zrušení xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě nařízení (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx xx čx.&xxxx;37 xxxx. 5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

xxxxxxxx k těmto xůxxxůx:

(1)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č.&xxxx;1272/2008 xxxxxxxx xxx xxxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 je xxxxxx xxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx základě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx v částech 2 xž 5 xř&xxxxxx;xxxx X&xxxx;xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008. V tabulce 3.2 xx uveden xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x xxxxčxx&xxxxxx; nebezpečných x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx v příloze XX xxěxxxxx Rady 67/548/XXX xx xxx 27.&xxxx;čxxxxx 1967 o sbližování xx&xxxxxx;xx&xxxxxx;xx a xxx&xxxxxx;xx&xxxxxx;xx xřxxxxxů x&xxxxxx;xxx&xxxxxx;x&xxxxxx;xx xx xxxxxxxxxxx, xxxxx&xxxxxx; a xxxxčxx&xxxxxx;x&xxxxxx; nebezpečných x&xxxxxx;xxx (2). Xxxx xxx xxxxxxx xx xxxx&xxxxxx; změnit, xxx xx nich xxxx xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx látek, na xxxx&xxxxxx; se xxž xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx, x aby zahrnovaly x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(2)

X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; xxxxx Xxxxxxx&xxxxxx; agentury xxx xxxxxxx&xxxxxx; látky (XXXX) vydal stanoviska x návrhům xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x xxxxčxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx, xxxx&xxxxxx; xxxx xřxxxxžxxx agentuře v xxxxxxx x článkem 37 nařízení (XX) č. 1272/2008. Xx x&xxxxxx;xxxxě xěxxxx xxxxxxxxxx x xx x&xxxxxx;xxxxě xřxxxx&xxxxxx;xxx xxxxžxx&xxxxxx;xx xx xxxčxx&xxxxxx;xx stran xx xřxxx změnit xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, aby xxxx dosaženo harmonizace xxxxxxxxxxx x xxxxčxx&xxxxxx;x&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(3)

Xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxxxxx&xxxxxx; v části 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx nařízení, xx se xxxěxx xxxž&xxxxxx;x xxxxxxxxřxxxě, neboť xxxxxx&xxxxxx;řxx&xxxxxx; subjekty xxxxx xxxřxxxxxx xxčxx&xxxxxx; období xx xx, xxx xxxxx xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; a balení x&xxxxxx;xxx a směsí x xxxxxx xxxxxxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxxxx&xxxxxx;řxx&xxxxxx; xxxxxxxx budou xxxxě xxxx potřebovat xxčxx&xxxxxx; časové xxxxx&xxxxxx; xx xx, xxx xxxxx xxxxxx xxxxxxxxxx xxx xxxxxxxxxx, které xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; pro xxxxxxxxxx, kategorií 1X x&xxxx;1X (tabulka 3.1) x&xxxx;xxxxxxxx&xxxxxx; 1 x&xxxx;2 (xxxxxxx 3.2) xxxx xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; xxxxxxxxx x&xxxx;xxžxxxx&xxxxxx; xxxxxxx dlouhodobé xxxř&xxxxxx;xxxx&xxxxxx; &xxxxxx;čxxxx ve xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, xxxx&xxxxxx;xx xxx xxxxxxxxxx stanovené x&xxxx;čx&xxxxxx;xxx&xxxx;23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Rady (XX) č.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx 2006 x&xxxx;xxxxxxxxxx, xxxxxxxx&xxxxxx;, xxxxxxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx x&xxxxxx;xxx, x&xxxx;xř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; x&xxxxxx;xxx, x&xxxx;xxěxě xxěxxxxx 1999/45/XX a o zrušení xxř&xxxxxx;xxx&xxxxxx; Xxxx (XXX) č.&xxxx;793/93, xxř&xxxxxx;xxx&xxxxxx; Xxxxxx (XX) č.&xxxx;1488/94, xxěxxxxx Xxxx 76/769/XXX x&xxxx;xxěxxxx Xxxxxx 91/155/XXX, 93/67/XXX, 93/105/XX x&xxxx;2000/21/XX (3).

(4)

X&xxxx;xxxxxxx x&xxxx;xřxxxxxx&xxxxxx;x xxxxxxxxx&xxxxxx;x xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxx&xxxxxx; xxxžňxxx xžxx&xxxxxx; nových xxxxxxxxx&xxxxxx; s předstihem xx x&xxxxxx;xx xxxxxxxxxxxxx, xx xěxx x&xxxxxx;x xxxxxxxxx&xxxxxx; xxžxxxx xxxž&xxxxxx;xxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx znění xxxxxx xxř&xxxxxx;xxx&xxxxxx;, x xřxxxůxxxxx označování x xxxxx&xxxxxx; odpovídajícím xxůxxxxx xx xxxxxxxxx&xxxxxx; x&xxxxxx;xx xřxx 1. xxxxxxxxx 2013.

(5)

Xxxxřxx&xxxxxx; stanovená tímto xxř&xxxxxx;xxx&xxxxxx;x xxxx x&xxxx;xxxxxxx xx stanoviskem x&xxxxxx;xxxx xř&xxxxxx;xxx&xxxxxx;xx xxxxx čx&xxxxxx;xxx 133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX TOTO XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx&xxxx;1

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 se xěx&xxxxxx; xxxxx:

1)

Xxxxxxx 3.1 se xěx&xxxxxx; xxxxx:

x)

x&xxxxxx;xxxxx, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x x příloze X, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx xxxxxxxx&xxxxxx;xx x&xxxx;xxxxxx&xxxxxx; xř&xxxxxx;xxxx;

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; v příloze XX xx vkládají x xxxxxxx x xxxxxxxxxxx&xxxxxx; x&xxxxxx;xxxxů xxxxxxxx&xxxxxx;xx x&xxxx;xxxxxxx 3.1

2)

Tabulka 3.2 xx mění takto:

x)

záznamy, xxxx&xxxxxx; odpovídají záznamům xxxxxx&xxxxxx;x x xř&xxxxxx;xxxx XXX, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx xxxxxxxx&xxxxxx;xx v uvedené xř&xxxxxx;xxxx;

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; v xř&xxxxxx;xxxx XX xx xxx&xxxxxx;xxx&xxxxxx; x souladu x posloupností x&xxxxxx;xxxxů xxxxxxxx&xxxxxx;xx x&xxxx;xxxxxxx 3.2

Čx&xxxxxx;xxx&xxxx;2

Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx dvacátým dnem xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Evropské xxxx.

Čx&xxxxxx;xxx 1 se použije xxx xxx 1. xxxxxxxx 2013.

Xxxxxxxxxxxx&xxxxxx; klasifikace xxxxxxxx&xxxxxx; x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xx xxěx&xxxxxx; tohoto xxř&xxxxxx;xxx&xxxxxx;, xxx xxxž&xxxxxx;x xřxx 1.&xxxx;xxxxxxxxx 2013.

Xxxx nařízení xx x&xxxxxx;xxxx&xxxxxx; x&xxxx;xxx&xxxxxx;x xxxxxxx x&xxxx;xř&xxxxxx;xx použitelné xx x&xxxxxx;xxx čxxxxx&xxxxxx;xx xx&xxxxxx;xxxx.

X Xxxxxxx dne 10. čxxxxxxx 2012.

Xx Xxxxxx

José Xxxxxx BARROSO

předseda

(1)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. 196, 16.8.1967, x. 1.

(3)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;136, 29.5.2007, x.&xxxx;3.

XŘ&Xxxxxx;XXXX&xxxx;X

Xxxxxxx&xxxxxx; číslo

Mezinárodní xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx, xxxxxxxxxxčx&xxxxxx; faktory

Pozn.

X&xxxxxx;xx xř&xxxxxx;x x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx vět x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx symbolů x xxxx&xxxxxx;xx&xxxxxx;xx xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx o xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

&xxxxx;009-016-00-2

trisodium xxxxxxxxxxxxxxxxxxx [1]

237-410-6 [1]

13775-53-6 [1]

XXXX RE 1

Xxxxx Xxx. 4

Aquatic Xxxxxxx 2

X372

X332

X411

XXX07

XXX08

XXX09

Xxx

X372

X332

X411

&xxxx;

&xxxx;

&xxxx;

xxxxxxxxx hexafluoroaluminate (xxxxxxxx) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-xxxxxxxxxxxxx;

ethylene xxxxxx xxxxxxxxx ether

203-804-1

110-80-5

Flam. Xxx. 3

Xxxx. 1X

Xxxxx Xxx. 3

Xxxxx Tox. 4

X226

X360XX

X331

X302

XXX02

XXX08

XXX06

Xxx

X226

X360XX

X331

X302

&xxxx;

&xxxx;

&xxxx;

603-025-00-0

xxxxxxxxxxxxxxx

203-726-8

109-99-9

Xxxx. Xxx. 2

Xxxx. 2

Xxx Xxxxx. 2

XXXX XX 3

H225

H351

X319

H335

XXX02

GHS07

XXX08

Dgr

H225

H351

H319

X335

XXX019

XXXX SE 3;

X335: X &xx; 25&xxxx;%

Xxx Xxxxx.2;

H319: X &xx; 25&xxxx;%

 

613-016-00-3

fuberidazole (XXX);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. 2

Xxxxx Xxx. 4

XXXX XX 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H302

H373 (xxxxx)

H317

X400

X410

XXX07

GHS08

GHS09

Xxx

X351

X302

X373 (xxxxx)

X317

X410

&xxxx;

X = 1

&xxxx;

617-001-00-2

xx-xxxx-xxxxx xxxxxxxx

203-733-6

110-05-4

Xxx. Xxxxx. E

Xxxx. Xxx. 2

Muta. 2

X242

H225

H341

XXX02

XXX08

Xxx

H242

X225

H341“

&xxxx;

 

 

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; číslo

Mezinárodní identifikace xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Č&xxxxxx;xxx ES

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; koncent. xxxxxx, xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

Kódy tříd x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

Kódy xxxxxxxxx&xxxxxx;xx vět x xxxxxxxčxxxxx

X&xxxxxx;xx výstražných symbolů x xxxx&xxxxxx;xx&xxxxxx;xx xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx o xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. standardních xěx o nebezpečnosti

&xxxxx;015-199-00-X

xxxx[2-xxxxxx-1-xxxxxxxxxxxx)xxxxx] xxxxxxxxx

237-159-2

13674-87-8

Xxxx. 2

X351

GSH08

Wng

H351

&xxxx;

&xxxx;

&xxxx;

015-200-00-3

xxxxxx xxxxxxxxx

244-959-5

22398-80-7

Xxxx. 1X

Xxxx. 2

XXXX XX 1

X350

X361x

X372 (xx&xxxxxx;xx)

GHS08

Xxx

H350

H361f

X372 (xx&xxxxxx;xx)

 

STOT XX 1;

X372: X&xxxx;&xx;&xxxx;0,1&xxxx;%

Carc 1X;

X350: X&xxxx;&xx;&xxxx;0,01&xxxx;%

STOT XX 2;

X373: 0,01&xxxx;%&xxxx;&xx; X&xxxx;&xx;&xxxx;0,1&xxxx;%

&xxxx;

015-201-00-9

trixylyl xxxxxxxxx

246-677-8

25155-23-1

Xxxx. 1X

H360F

XXX08

Xxx

X360X

&xxxx;

&xxxx;

&xxxx;

015-202-00-4

xxxx(xxxxxxxxxxx) xxxxxxxxx

247-759-6

26523-78-4

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

H400

X410

XXX07

GHS09

Wng

X317

X410

&xxxx;

&xxxx;

&xxxx;

015-203-00-X

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxx xxxxx

278-355-8

75980-60-8

Xxxx. 2

H361f (způsobuje xxxxxxx xxxxxx)

XXX08

Wng

X361x (způsobuje xxxxxxx xxxxxx)

&xxxx;

 

&xxxx;

602-109-00-4

Xxxxxxxxxxxxxxxxxxxxxx [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. 2

Lact.

X361

H362

XXX08

Wng

H361

H362

 

&xxxx;

&xxxx;

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

xxxxxxxxx (xxxxxxxxxxx xx avermectin X1x xxx avermectin X1x) (XXX) [1]

_ [1]

71751-41-2 [1]

Xxxx. 2

Xxxxx Xxx. 2

Acute Xxx. 1

XXXX RE 1

Aquatic Xxxxx 1

Aquatic Xxxxxxx 1

X361x

X300

X330

X372 (nervový xxxx&xxxxxx;x)

H400

X410

XXX06

GHS08

XXX09

Dgr

X361x

H300

X330

X372 (xxxxxx&xxxxxx; systém)

H410

&xxxx;

STOT XX 1;

X372: X&xxxx;&xx;&xxxx;5&xxxx;%

XXXX XX 2;

X373: 0,5&xxxx;%&xxxx;&xx; C < 5 %

X&xxxx;=&xxxx;10&xxxx;000

&xxxx;

xxxxxxxxxx X1x (purity &xx;&xxxx;80&xxxx;%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx acetate

&xxxxx;

57960-19-7

Xxxx Xxxx. 1

XXXX XX 1

STOT XX 2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X317

X370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (xxxxx&xxxxxx; xxěx)

X400

H410

GHS07

XXX08

XXX09

Xxx

H317

X370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (xxxxx&xxxxxx; xxěx)

H410

&xxxx;

M = 1 000

&xxxx;

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. 1B

STOT XX 1

Xxxxx Tox. 4

X360X

H372

H302

XXX07

GHS08

Xxx

H360F

H372

X302

&xxxx;

 

 

612-281-00-2

xxxxxxxxxxxxxx xxxxx;

X,X,X',X'-xxxxxxxxxxx-4,4'-xxxxxxxxxxxxxxxxxxxx

204-961-9

129-73-7

Xxxx. 2

Xxxx. 2

H351

X341

GHS08

Wng

H351

X341

&xxxx;

&xxxx;

&xxxx;

616-205-00-9

Xxxxxxxxxxx (XXX);

2-xxxxxx-X-(2,6-xxxxxxxxxxxxxx)-X-(1X-xxxxxxx-1-xxxxxxxx)xxxxxxxxx

266-583-0

67129-08-2

Xxxx Xxxx. 1X

Carc. 2

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H317

X351

X400

H410

XXX07

GHS08

XXX09

Xxx

H317

X351

X410

&xxxx;

X&xxxx;=&xxxx;100

X&xxxx;=&xxxx;100&xxxxx;

 

XŘ&Xxxxxx;XXXX&xxxx;XXX

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Č&xxxxxx;xxx XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

&xxxxx;009-016-00-2

xxxxxxxxx hexafluoroaluminate [1]

237-410-6 [1]

13775-53-6 [1]

Xx; X20

X; X48/23/25

N; R51-53

X; X

X: 20-48/23/25-51/53

S: (1/2-)22-37-45-61

&xxxx;

&xxxx;

xxxxxxxxx xxxxxxxxxxxxxxxxxxx (xxxxxxxx) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-ethoxyethanol;

ethylene xxxxxx xxxxxxxxx xxxxx

203-804-1

110-80-5

R10

Xxxx. Cat. 2; R60-61

Xx; X20/22

T

R: 60-61-10-20/22

X: 53-45

&xxxx;

X

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

F; R11-19

Xxxx. Xxx. 3; R40

Xx; X36/37

X; Xn

X: 11-19-40-36/37

X: (2-)(13-)16-29-33-36-37(-46)

Xx; R36/37: X&xxxx;&xx;&xxxx;25&xxxx;%

&xxxx;

613-016-00-3

xxxxxxxxxxxx (XXX);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. Xxx. 3; X40

Xx; X48/22

Xx; X22

Xx; X43

X; R50-53

Xx; N

X: 40-48/22-22-43-50/53

X: (2)-22-36/37-60-61

X; X50-53: X&xxxx;&xx;&xxxx;25&xxxx;%

X; R51-53: 2,5&xxxx;%&xxxx;&xx;&xxxx;X&xxxx;&xx;&xxxx;25&xxxx;%

R52-53: 0,25&xxxx;%&xxxx;&xx;&xxxx;X&xxxx;&xx;&xxxx;2,5&xxxx;%

&xxxx;

617-001-00-2

xx-xxxx-xxxxx xxxxxxxx

203-733-6

110-05-4

O; X7

X; X11

Xxxx. Xxx. 3, X68

X; X; Xx

X: 7-11-68

X: (2-)3/7-14-16-23-36/37/39&xxxxx;

&xxxx;

&xxxx;

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; číslo

Xxxxx&xxxxxx;xxxx&xxxxxx; identifikace xxxxxxx&xxxxxx;xx látek

Číslo XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

&xxxxx;015-199-00-X

tris[2-chloro-1-chloromethyl)ethyl] xxxxxxxxx

237-159-2

13674-87-8

Xxxx. Xxx. 3; X40

Xx

X: 40

X: (2-)36/37

&xxxx;

&xxxx;

015-200-00-3

indium xxxxxxxxx

244-959-5

22398-80-7

Xxxx. Xxx. 2; X45

Repr. Xxx. 3; R62

T; X48/23

X

X: 45&xxxxx;48/23&xxxxx;62

X: 45- 53

X; R48/23: X &xx;0,1%

Xxxx Cat 2; X45: X &xx; 0,01%

Xx; R48/20: 0,01%≤ X &xx; 0,1%

X

015-201-00-9

xxxxxxxx xxxxxxxxx

246-677-8

25155-23-1

Xxxx. Xxx. 2; X60

X

X: 60

X: 53-45

 

&xxxx;

015-202-00-4

xxxx(xxxxxxxxxxx) xxxxxxxxx

247-759-6

26523-78-4

Xx; X43

X; R50-53

Xx; X

X: 43-50/53

S: 24-37-60-61

&xxxx;

 

015-203-00-X

diphenyl(2,4,6-trimethylbenzoyl)phosphine xxxxx

278-355-8

75980-60-8

Xxxx. Xxx. 3; X62

Xx

X: 62

X: (2)-22-36/37.

 

&xxxx;

602-109-00-4

Xxxxxxxxxxxxxxxxxxxxxx [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. Cat. 3; X63 X64

Xx

X: 63-64

X: 36/37-53

&xxxx;

&xxxx;

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxxxx [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

xxxxxxxxx (combination xx avermectin B1a xxx xxxxxxxxxx X1x) (XXX) [1]

_ [1]

71751-41-2 [1]

Xxxx. Cat. 3; R63

X+; X26/28

X; X48/23/25

N; R50-53

X+; X

X: 63-26/28-48/23/25-50/53

S: 28-36/37-45-60-61

X; X48/23: X ≥ 5%

Xx; R48/20: 0,5% &xx; X <5%

N; X50-53: X ≥ 0,0025%

X; X51-53: 0,00025% &xx; X &xx;0,0025%

X52-53: 0,000025% ≤ C<0,00025%

 

xxxxxxxxxx X1x (xxxxxx ≥80%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx acetate

&xxxxx;

57960-19-7

X; X39/23

Xx; X43

X; R50-53

T; N

X: 39/23-43-50/53,

X: (2-)24-37-38-60-61

X; X50-53: X &xx; 0,025%

N; X51-53: 0,0025% ≤ X < 0,025%

X52-53: 0,00025% &xx; X &xx; 0,0025%

&xxxx;

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. Xxx. 2; X60

T; X48/23/24/25

Xx; R22

X

R: 60-22-48/23/24/25

S: 53-45

&xxxx;

X

612-281-00-2

xxxxxxxxxxxxxx xxxxx

N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline

204-961-9

129-73-7

Carc. Xxx.&xxxx;3;X40

Muta. Xxx. 3; X68

Xn

X: 40-68

X: (2-)36/37

 

&xxxx;

616-205-00-9

Metazachlor (XXX);

2-xxxxxx-X-(2,6-xxxxxxxxxxxxxx)-X-(1X-xxxxxxx-1-xxxxxxxx)xxxxxxxxx

266-583-0

67129-08-2

X43

Carc. Xxx. 3; R40

X; X50-53

Xx; N

X: 40-43-50/53

S: (2-)36-37-60-61

X; R50-53: X &xx; 0,25%

N; X51-53: 0,025% ≤ C &xx; 0,25%

X52-53: 0,0025% &xx; C &xx; 0,025%&xxxxx;

&xxxx;